755 filings
Page 31 of 38
SC 13G/A
AERI
Aerie Pharmaceuticals Inc
5 Feb 16
Aerie Pharmaceuticals Inc
12:00am
SC 13G/A
AERI
Aerie Pharmaceuticals Inc
28 Jan 16
Aerie Pharmaceuticals Inc
12:00am
SC 13G
AERI
Aerie Pharmaceuticals Inc
28 Jan 16
Aerie Pharmaceuticals Inc
12:00am
SC 13G/A
AERI
Aerie Pharmaceuticals Inc
19 Jan 16
Aerie Pharmaceuticals Inc
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
11 Jan 16
Any discussion of the potential use or expected success of our product candidates is subject to our
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
16 Nov 15
Regulation FD Disclosure
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
13 Nov 15
Regulation FD Disclosure
12:00am
10-Q
2015 Q3
AERI
Aerie Pharmaceuticals Inc
Quarterly report
6 Nov 15
12:00am
424B5
AERI
Aerie Pharmaceuticals Inc
6 Nov 15
Prospectus supplement for primary offering
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
3 Nov 15
Results of Operations and Financial Condition
12:00am
SC 13G
Integrated Core Strategies
25 Sep 15
Aerie Pharmaceuticals Inc
12:00am
SC 13G
AERI
Aerie Pharmaceuticals Inc
25 Sep 15
Aerie Pharmaceuticals Inc
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
24 Sep 15
Regulation FD Disclosure
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
21 Sep 15
Regulation FD Disclosure
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
16 Sep 15
Aerie Pharmaceuticals Reports Positive RhopressaTM Phase 3 Efficacy Results
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
9 Sep 15
Aerie Pharmaceuticals Announces that Richard A. Lewis, M.D., Has Joined as Chief Medical Officer
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
8 Sep 15
Regulation FD Disclosure
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
12 Aug 15
Any discussion of the potential use or expected success of our product candidates is subject to our
12:00am
10-Q
2015 Q2
AERI
Aerie Pharmaceuticals Inc
Quarterly report
6 Aug 15
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
5 Aug 15
Results of Operations and Financial Condition
12:00am